
Esperion Therapeutics ESPR
€ 2.80
-2.08%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Esperion Therapeutics DPO 2011-2026 | ESPR
DPO Jährlich Esperion Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 7.93 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.93 K | 7.93 K | 7.93 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alector
ALEC
|
13.8 | $ 2.19 | -9.77 % | $ 226 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Codexis
CDXS
|
98.4 | $ 1.02 | 1.49 % | $ 74.9 M | ||
|
Cerus Corporation
CERS
|
242 | $ 2.6 | 1.37 % | $ 480 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Cellectis S.A.
CLLS
|
975 | $ 3.87 | -0.39 % | $ 116 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Collegium Pharmaceutical
COLL
|
34.6 | $ 41.75 | 0.19 % | $ 1.32 B | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
785 | $ 36.14 | 1.23 % | $ 3.75 B | ||
|
Amarin Corporation plc
AMRN
|
190 | $ 13.98 | 1.27 % | $ 5.7 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
58.1 | $ 23.77 | 2.99 % | $ 2.91 B | ||
|
Cardiff Oncology
CRDF
|
406 | $ 1.94 | 0.01 % | $ 130 M | ||
|
Curis
CRIS
|
3.24 K | $ 1.1 | -3.51 % | $ 6.94 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
CorMedix
CRMD
|
216 K | $ 7.16 | 0.42 % | $ 364 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Champions Oncology
CSBR
|
64.6 | $ 6.14 | 3.89 % | $ 83.9 M |